Hamel Lawrence G 4
4 · ACELRX PHARMACEUTICALS INC · Filed Jan 26, 2018
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-22+95,000→ 95,000 totalExercise: $2.00From: 2019-01-22Exp: 2028-01-21→ Common Stock (95,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
- [F2]Issued pursuant to the 2011 Equity Incentive Plan.